Safety and Adequacy of Kidney Biopsy Procedure in Patients with Obesity. Issue 1 (January 2023)

• Record Type: Journal Article
• Authors: Qian, Long; Menez, Steven; Hu, David; Weinstein, Jason; Melchinger, Hannah; Thiessen-Philbrook, Heather; Luciano, Randy L.; Turner, Jeffrey M.; Perazella, Mark A.; Corona Villalobos, Celia Pamela; Shaw, Melissa M.; Wilson, F. Perry; Parikh, Chirag R.; Moledina, Dennis G.
• Is Part Of: Kidney360. Volume 4:Issue 1(2023)
• Page Start: 98
• Page End: 101
• Publication Date: 2023-01
• Subjects: obesity -- kidney biopsy -- pathology; 616.61
• DOI: 10.34067/KID.0006602022
• Languages: English
• ISSNs: 2641-7650

Abstract

Key Points: Patients with obesity did not have any larger hematocrit drop after kidney biopsy compared with those without obesity. Patients with obesity had fewer glomeruli sampled from kidney biopsy compared with those without obesity. For patients with obesity, kidney biopsy is a safe procedure but may have lower diagnostic adequacy.